BRSF (Brain Scientific) EBITDA Margin %: -2,060.00% (As of Dec. 2022)


BRSF Brain Scientific Inc BRSF
10 GF Score
Price $0.00
View Full Analysis

What is Brain Scientific EBITDA Margin %?

Brain Scientific BRSF 10 EBITDA Margin % is -2,060.00% as of Dec. 2022. GuruFocus rates BRSF with a GF Score™ of 10/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Brain Scientific's EBITDA for the three months ended in Dec. 2022 was $-0.10 Mil. Brain Scientific's Revenue for the three months ended in Dec. 2022 was $0.01 Mil. Therefore, Brain Scientific's EBITDA margin for the quarter that ended in Dec. 2022 was -2,060.00%.

Brain Scientific  (OTCPK:BRSF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Brain Scientific EBITDA Margin % Related Terms

Brain Scientific EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Brain Scientific's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brain Scientific EBITDA Margin % Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
EBITDA Margin %
-3,128.95 -3,680.93

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EBITDA Margin % Get a 7-Day Free Trial -1,972.91 -1,065.00 -1,836.84 -37,145.45 -2,060.00

BRSF vs MOTS, BRSF, PBIO: EBITDA Margin % Comparison

For the Medical Devices subindustry, Brain Scientific's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brain Scientific EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Brain Scientific's EBITDA Margin % falls into.


BRSF
10GF Score
Brain Scientific Inc BRSF
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brain Scientific EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Brain Scientific's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-7.914/0.215
=-3,680.93 %

Brain Scientific's EBITDA Margin % for the quarter that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=-0.103/0.005
=-2,060.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -2,060.00% mean?
Brain Scientific (BRSF) has a EBITDA Margin % of -2,060.00% as of Dec. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Brain Scientific and its competitors.
Is Brain Scientific's EBITDA Margin % too high?
Brain Scientific's current EBITDA Margin % is -2,060.00%. Overall, Brain Scientific has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Brain Scientific's EBITDA Margin % compare to MOTS and BRSF?
Brain Scientific's EBITDA Margin % of -2,060.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Brain Scientific and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brain Scientific's current EBITDA Margin % is -2,060.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brain Scientific stock overvalued right now?
Brain Scientific (BRSF) has a current EBITDA Margin % of -2,060.00%. The current EBITDA Margin % is -2,060.00%. Brain Scientific's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Brain Scientific (BRSF), the current EBITDA Margin % is -2,060.00% as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brain Scientific Business Description

Address 6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
10GF Score

Get the complete analysis for BRSF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price